Tumor-associated antigens: from discovery to immunity

Related Experiment Video

Updated: Sep 20, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Jennifer D Lewis1, Brian D Reilly, Robert K Bright

  • 1Department of Microbiology and Immunology and the Southwest Cancer Center, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA.

International Reviews of Immunology
|September 10, 2003
PubMed

Insights

Therapeutic cancer vaccines are evolving from whole-cell approaches to defined tumor-associated antigens (TAAs). Research focuses on identifying TAAs and developing novel delivery strategies for effective cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Vaccine Development

Background:

  • Early cancer vaccines utilized whole tumor cells or lysates, yielding limited therapeutic success.
  • This necessitated the development of more targeted approaches for cancer immunotherapy.

Purpose of the Study:

  • To review the shift towards next-generation cancer vaccines based on defined tumor-associated antigens (TAAs).
  • To highlight ongoing research in TAA identification and therapeutic vaccine delivery strategies.

Main Methods:

  • Review of historical and current research in cancer vaccine development.
  • Focus on the definition and characterization of tumor-associated antigens (TAAs).

Main Results:

  • Limited efficacy of early whole-cell tumor vaccines.
  • Significant research efforts directed towards TAAs for improved cancer immunotherapy.

Conclusions:

  • Renewed enthusiasm exists for therapeutic cancer vaccination.
  • Continued research in TAA discovery and novel vaccine delivery is crucial for advancing cancer treatment.

More Related Videos

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment06:32

Multiplex Immunohistochemical Analysis of the Spatial Immune Cell Landscape of the Tumor Microenvironment

Published on: August 18, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...